Total medical devices industry cross border deals worth $3.5bn were announced globally for May 2021, with the $830m private equity deal with Caris Life Sciences being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 11.1% over the previous month of $3.97bn and a rise of 17.3% when compared with the last 12-month average of $3.01bn.
In terms of number of cross border deals, the sector saw a rise of 25.00% with 50 deals in May 2021 when compared to the last 12-month average of 40 deals.
In value terms, North America led the activity with cross border deals worth $2.22bn in May 2021.
Medical Devices industry cross border deals in May 2021: Top deals
The top five cross border deals accounted for 62.1% of the overall value during May 2021.
The combined value of the top five cross border deals stood at $2.2bn, against the overall value of $3.5bn recorded for the month.
The top five medical devices industry cross border deals of May 2021 tracked by GlobalData were:
1) L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment’s $830m private equity deal with Caris Life Sciences
2) The $540m venture financing of Noom by Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)
3) NeoGenomics’ $390m acquisition of Inivata
4) The $235m private equity deal of Cue Health by ACME Capital, CAVU Venture Partners, Decheng Capital, Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms, MSD Capital and Perceptive Advisors
5) China Investment, EDBI, Novo Holdings and Vivo Capital’s venture financing deal with Esco Micro for $200m.
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.